Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.

Vertex Pharmaceuticals (NASDAQ: VRTX)

VRTX 184.27
1.53 (0.8%)

Open: 186.12 High: 186.44 Low: 182.60


External Links

52WL $182.60

The 52 Week Low is $182.60 set on Wed, Sep 22, 2021.

52WH $280.99

The 52 Week High is $280.99 set on Tue, Oct 13, 2020. The current price, $184.27, is 34% below the 52 Week High.

ATH $304.00

The All-Time High is $304.00 set on Mon, Jul 20, 2020. The current price, $184.27, is 39% below the All Time High.

52 Week Range

Sep 22, 2021
Oct 13, 2020

VRTX Earnings

Q1 Earnings for Jan, Feb & Mar

Thu, Apr 29, 2021

Since Q1 Earnings Report

VRTX 13.7%

Q2 Earnings for Apr, May & Jun

Thu, Jul 29, 2021

Since Q2 Earnings Report

VRTX 8.9%

VRTX Profile

Vertex Pharmaceuticals trades on the NASDAQ. VRTX's market cap is 47.7 Billion.

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex's pipeline includes gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease as well as small-molecule medicines targeting diseases associated with alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease. Vertex also has an expanding research pipeline focused on inflammatory diseases, non-opioid treatments for pain, and genetic and cell therapies for type 1 diabetes and rare diseases.


Related Channels

YouTube Symbol Surfing

Watch these videos to learn how Symbol Surfing can increase your trading and investing knowledge and results.